100
Participants
Start Date
October 31, 2002
Study Completion Date
April 30, 2005
placebo
Placebo comparator to be given per protocol.
sildenafil
oral sildenafil citrate at an initial dose of 25 mg, which could have been up-titrated to 50 mg at Visit 3 based on the patient's efficacy, safety and tolerability responses; at Visits 4 and 5, the dose could remain the same, be increased to 100 mg, or decreased to 25 mg depending on the safety, efficacy, and tolerability
Pfizer Investigational Site, Fortaleza
Pfizer Investigational Site, Belo Horizonte
Pfizer Investigational Site, Belo Horizonte
Pfizer Investigational Site, São José do Rio Preto
Pfizer Investigational Site, Londrina
Pfizer Investigational Site, Jaú
Pfizer Investigational Site, Sorocaba
Pfizer Investigational Site, São Paulo
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY